Deal makers took a break last week, after a long trudge through the J.P. Morgan Healthcare Conference the week before. Deal volume was light in the week of Janaury 17, 2018, but at least 70 transactions have been recorded this month. Here’s an unusual deal from the eHealth sector we picked.

Elsevier, a subsidiary of RELX plc (NYSE: RELX), announced its acquisition of Via Oncology, a privately held, former subsidiary of UPMC, based in Pittsburgh. Elsevier is a global provider of information solutions for science, health and technology professionals.

Via Oncology provides decision support tools for cancer. Specifically, its Via Pathways product helps cancer centers demonstrate the value of their care to patients, referring physicians and payers by developing and implementing clinical pathways in collaboration with its network of more than 1,500 U.S. cancer care providers.

Via Oncology’s Via Pathways addresses more than 2,000 unique patient presentations, including expert-defined clinical algorithms and specific recommendations for all significant aspects of cancer care. The acquisition enables Elsevier to support the referential needs of caregivers and the workflow needs of clinicians.

Financial terms were not disclosed.